semaglutide and zyrtec GLP-1 Meds (Weight Loss) Allergy Meds—OK Together? and reduced Red bump/mark at injection site?

In contrast, for wellness use with normal labs, the rationale is weaker and alternatives should be discussed

2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)

Managing your medication storage and your overall health during summer months requires a holistic approach

Why real-world escalation often takes longer In clinical trials, escalation timelines are fixed

This ensured unbiased allocation and reduced potential confounding factors